Edward Zhou
President of China, Biotechnology Group

Edward Zhou devotes great time and energy to developing people and emphasizing their strengths. That is his secret to making business grow healthy and fast. In his current role as President of China for both Pall Life Sciences and Cytiva, he leads a team driven to serve the customer in a rapidly expanding industry.

As a young technician in Shanghai in the 1990s, he supervised manufacturing processes. Since then, this foundational experience has helped him build a career that has spanned sales, consumer devices, hospital devices, product management and business leadership.

Edward joined the Danaher Biotechnology Group in 2022 directly from Johnson & Johnson Medical China Ltd’s surgical portfolio Ethicon, where he spent seven years. There, he led 2,200 people toward USD 1.6B in revenue.

During his wide-ranging experience at different J&J businesses, including the Personal Care business, Beijing Dabao Cosmetics Company, and Vision Care, he has handled different business challenges including three turnarounds and a high-growth environment. He has managed multi-million-dollar acquisition deals in China. Edward has worked and lived in the United Kingdom and Singapore before returning to China in 2012.

Edward holds a bachelor’s degree in Science in Biochemistry and a master’s degree of Business Administration from Fudan University in China.